Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2033

Annual patent cliff calendar for 2033 — US pharmaceutical patents by expiration date.

Patents
1,330

Quick answer

1,330 indexed pharmaceutical patents have expiration dates in 2033. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8563503

    Antibiotic, its nucleotide sequence, methods of construction and uses thereof

    PROTEIN DESIGN LAB, LTD. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8563314

    Methods and compositions for modulating PD1

    Sangamo Biosciences, Inc. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8563039

    Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions

    Anika Therapeutics S.r.l. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8563035

    Oral tablet compositions of dexlansoprazole

    Sanovel Ilac Sanayi Ve Ticaret Anomin Sirketi · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8563022

    Particles for cell targeting

    The Board of Regents of the University of Texas System · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8563023

    Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

    Covidien LP · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8563014

    Modafinil oral lyophilizate

    Teva Sante · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8563001

    Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease

    Regents of the University of Minnesota · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8562955

    Light-activated tooth whitening method

    DISCUS DENTAL, LLC · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8562949

    Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8562948

    Somatostatin analogs with inhibitory activity to growth hormone release

    The Regents of the University of California · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8562589

    Swallowable drug delivery device and method of delivery

    Rani Therapeutics, LLC · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8562965

    Polymer derivatives comprising an acetal or ketal branching point

    Nektar Therapeutics · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8563026

    Protein-based artificial retinas

    UNIVERSITY OF CONNECTICUT · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8563028

    Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication

    The Regents of the University of California · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8563269

    Modified antibody compositions, methods of making and using thereof

    CytomX Therapeutics, Inc. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8563512

    Neprilysin inhibitors

    Theravance, Inc. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8563559

    Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8563595

    Treatment of cancer with complex organic-inorganic pigment compositions

    The Board of Regents of the University of Texas System · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. EP 2651400

    ORALE RETARD-DARREICHUNGSFORMEN VON SCHWER LÖSLICHEN ARZNEIMITTELN UND IHRE VERWENDUNG

    CELGENE CORP [US] · Granted Wed Oct 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Oct 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. CA 2870399

    POLYPEPTIDES DE PROFILINE VEGETALE DESTINES A ETRE UTILISES DANS L'IMMUNOTHERAPIE NON SPECIFIQUE D'ALLERGIES

    ALK ABELLO AS [DK] · Granted Thu Oct 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8569448

    NMDAR biomarkers for diagnosis and treatment of traumatic brain injury and other disorders

    GRACE LABORATORIES, LLC · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8569351

    Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity

    Theravance, Inc. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8568739

    Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8569337

    Tri-cyclic pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8569340

    AMPK-activating piperidinyloxypyiridine carboxamide and sulfonamide compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8569320

    Topical composition for the treatment of actinic keratosis

    Almirall Hermal GmbH · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8569253

    Methods and compositions for gene inactivation

    Sangamo Biosciences, Inc. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8569249

    Method for inhibiting activation of macrophages

    China Medical University · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8569028

    Method for encapsulation of microparticles

    The United States of America, as represented by the Secretary of the Agriculture · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8569377

    Methods for treating spinal cord injury with a compound that inhibits a NCCA-ATP channel

    The United States of America as represented by the Department of Veteran Affairs · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8568756

    Inhibition of quorum sensing-mediated processes in bacteria

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8569379

    Use of rasagiline for the treatment of olfactory dysfunction

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8569242

    Method of treating degenerative disorders of the nervous system

    The Regents of the University of California · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8568977

    Compositions and methods for diagnosis and treatment of tumors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8568713

    Super fast-acting insulin compositions

    HALOZYME, INC. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8569380

    Oligomer-tricyclic conjugates

    Nektar Therapeutics · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8568705

    Method for preparing branched functionalized polymers using branched polyol cores

    Nektar Therapeutics · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8568721

    Method of treating rheumatoid arthritis with an anti-IL-6R antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8569343

    Oligomer-opioid agonist conjugates

    Nektar Therapeutics · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8568769

    Particle-containing complex porous materials

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8568714

    Lys K endolysin is synergistic with lysostaphin against MRSA

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8569225

    Targeting complement factor H for treatment of diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. EP 2656851

    Semuloparin zur Verbesserung der Überlebenschance von Krebspatienten

    AVENTIS PHARMA SA [FR] · Granted Wed Oct 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Oct 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 2013289070

    Use of Levocabastine for Modulating Generation of Pro-Inflammatory Cytokines

    BAUSCH & LOMB [US] · Granted Thu Oct 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8575165

    Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8575167

    Spiro compounds having stearoyl-CoA desaturase action

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8575170

    Flurbiprofen analogs and methods of use in treating cancer

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2033?

1,330 published patents in our USPTO index have expiration dates falling in calendar year 2033.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.